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Background
• No previous studies have evaluated the breadth & 
depth of endocrine curricula at United States (US) 
schools & colleges of pharmacy
• Most endocrine topics are considered “Tier I” or 
“Tier 2” in the ACCP Pharmacotherapy Toolkit, 
suggesting they must be sufficiently covered to 
prepare students to provide care upon graduation 
and licensure.1
• As PharmD curricula expand and content is 
removed or downsized, it is important to identify 
what content to retain/prioritize 
Objective
• To determine the breadth and depth of endocrine 
instruction and assessment within pre-APPE 
coursework in the clinical sciences across US 
PharmD programs
Methods
• Cross-sectional survey-based study
• Seventeen-question Qualtrics® survey distributed 
electronically to one targeted individual at each US 
PharmD program determined as most likely to be 
teaching with the endocrine curriculum
• Items included evaluation of specific endocrine 
content, contact hours, assessment strategies, and 
Entrustable Professional Activities (EPAs)
• Inclusion Criteria: US schools & colleges of 
pharmacy that are accredited by or in candidate 
status with the Accreditation Council for Pharmacy 
Education 
• Statistical Methods: Data were summarized using 
descriptive statistics. Chi-square tests were used to 
assess the association between categorical 
variables (Fisher’s exact tests used instead when 
expected frequencies < 5). Mann-Whitney-U tests 
and Kruskal-Wallis tests were used for evaluating 
ordinal variables. A priori significance level was set 
at 0.05.
• IRB Approval: Exempt status approval by 
Presbyterian College IRB
Results
• Fifty-eight of 142 (40.8%) programs participated. 
• Coverage of topics and contact hours varied 
considerably (Panels 1-3)
• For 10 topics, the perception of topic importance 
differed between programs that cover and those that 
do not cover the topic (p<0.05) (Panel 4)
• The most common assessment strategies were 
case studies, multiple choice questions, SOAP note 
writing and skills demonstration, though other 
methods are also used (Panel 5)
• Inclusion of diabetes-related EPAs was generally 
consistent across programs (Panel 6)
• Lack of curricular time was the most commonly cited 
barrier to covering additional endocrine topics, 
followed by faculty perceptions of importance and 
availability of faculty expertise. (Panel 7) 
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• There is inconsistency in endocrine curricular across US PharmD programs, including topics covered, 
contact hours, assessment strategies, and perception of topic importance
• There is a disparity between what is covered in didactic coursework (most topics covered in >70% of 
programs) and what is reinforced through laboratory coursework (only type 2 diabetes present in 
required labs for >50% of programs)
• There is wide variation in the number of contact hours dedicated to endocrine coursework in clinical 
sciences
• In general, “Tier 1” topics in the ACCP Pharmacotherapy Toolkit1 were consistently present in required 
coursework, “Tier 3” topics were generally absent, and the most variation was observed for topics falling 
within “Tier 2”
• Several discrepancies were noted between coverage & faculty perception of importance of various 
topics, such as:
• Gender affirming hormone therapy: 53% of programs responded not covering anywhere in the 
curriculum, although there was a wide range in responses regarding perceived importance
• Prediabetes: 100% of programs responded it’s at least moderately important, yet 7% of programs 
not currently covering in required didactic coursework
• Despite the variety of approaches, respondents consistently noted their methods were appropriately 
educating student pharmacists to develop diabetes-related EPAs.
